Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, +1

The Lancet

Metabolic SyndromeDiabetes ManagementGlucagon-like Peptide 1DiabetesPhysiology +7

Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes

Mette Zander, Mustafa Taskiran, M. Toft-Nielsen, +2

Diabetes Care

Video consultations as add-on to standard care among patients with type 2 diabetes not responding to standard regimens: a randomized controlled trial

Caroline Raun Hansen, Hans Perrild, Birgitte Gade Koefoed, +1

European Journal of Endocrinology

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study

Rebekka Faber, Mette Zander, Adam Peña, +3

Cardiovascular Diabetology

Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes

Nicole Jacqueline Jensen, Malin Nilsson, Jonas Schultz Ingerslev, +7

European Journal of Endocrinology

Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial

Malin Nilsson, Nicole Jacqueline Jensen, Michael Gejl, +5

Diabetologia

Diabetes ManagementAlzheimer's DiseasePsychiatryDementiaDiabetes +8

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

Mette Zander, Allan Christiansen, Sten Madsbad, +1

Diabetes Care

Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes

Kjeld Hermansen, Stein Vaaler, Sten Madsbad, +4

Metabolism

Type 1Diabetes ManagementInsulin ManagementDiabetesBiphasic Insulin Aspart +5

Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction

Hannah Elena Suhrs, Kristoffer Flintholm Raft, K. Bove, +4

International Journal of Cardiology

ObesityMetabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicine +8

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study

Hannah Elena Suhrs, Malin Nilsson, K. Bove, +2

PLoS ONE